Sigilon Therapeutics, Inc. Annual Return On Equity in % from 2020 to 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Sigilon Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2020 to 2022.
  • Sigilon Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2023 was -83.9 %, a 8.94% increase year-over-year.
  • Sigilon Therapeutics, Inc. annual Return On Equity for 2022 was -87.2 %, a 15.8% decline from 2021.
  • Sigilon Therapeutics, Inc. annual Return On Equity for 2021 was -75.3 %, a 156% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 -87.2 -11.9 -15.8% Jan 1, 2022 Dec 31, 2022
2021 -75.3 -211 -156% Jan 1, 2021 Dec 31, 2021
2020 136 Jan 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.